Dry powder cationic lipopolymeric nanomicelle inhalation for targeted delivery of antitubercular drug to alveolar macrophage
Mithun Varghese Vadakkan,1 K Annapoorna,2 KC Sivakumar,3 Sathish Mundayoor,2 GS Vinod Kumar1 1Chemical Biology, 2Mycobacterium Research Group, 3Bioinformatics Facility, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India Abstract: Excipients having self-assembling properties are...
Guardado en:
Autores principales: | Vadakkan MV, Annapoorna K, Sivakumar KC, Mundayoor S, Kumar GSV |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/99d849c436d14de1bca156f03ed3e3c6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Understanding the Importance of Capsules in Dry Powder Inhalers
por: Francesca Buttini, et al.
Publicado: (2021) -
Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler
por: HF Salem, et al.
Publicado: (2011) -
New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis
por: Duret C, et al.
Publicado: (2012) -
Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats
por: Li Z, et al.
Publicado: (2016) -
SYNTHESIS AND ANTITUBERCULAR ACTIVITY OF PYRIDAZINONE DERIVATIVES
por: HUSAIN,ASIF, et al.
Publicado: (2011)